Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections, today announced data from the company's ...
This is a letter to the editor in response to a March 13 article by Shelden Sones, RPh, FASCP titled “Is It True You Can’t Use Multiple Dose Vials Anymore?” written by Elliott S. Greene, MD, professor ...